Day One Biopharmaceuticals, Inc.
DAWN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $131,161 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $5,279 | $383 | $531 | $199 |
| Gross Profit | $125,882 | -$383 | -$531 | -$199 |
| % Margin | 96% | – | – | – |
| R&D Expenses | $227,702 | $130,521 | $85,618 | $43,584 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $115,450 | $75,160 | $60,760 | $28,960 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $343,152 | $205,681 | $146,378 | $72,544 |
| Operating Income | -$217,270 | -$206,064 | -$146,909 | -$72,743 |
| % Margin | -165.7% | – | – | – |
| Other Income/Exp. Net | $128,918 | $17,147 | $4,728 | -$11 |
| Pre-Tax Income | -$88,352 | -$188,917 | -$142,181 | -$72,754 |
| Tax Expense | $7,144 | $0 | $0 | $0 |
| Net Income | -$95,496 | -$188,917 | -$142,181 | -$70,645 |
| % Margin | -72.8% | – | – | – |
| EPS | -1.02 | -2.37 | -2.02 | -1.14 |
| % Growth | 57% | -17.3% | -77.2% | – |
| EPS Diluted | -1.02 | -2.37 | -2.02 | -1.14 |
| Weighted Avg Shares Out | 93,624 | 79,773 | 65,467 | 61,952 |
| Weighted Avg Shares Out Dil | 93,624 | 79,773 | 65,467 | 61,952 |
| Supplemental Information | – | – | – | – |
| Interest Income | $19,701 | $17,187 | $4,746 | $4 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2,029 | $383 | $531 | $199 |
| EBITDA | -$86,323 | -$188,534 | -$141,650 | -$72,555 |
| % Margin | -65.8% | – | – | – |